Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Total Debt (2019 - 2025)

Pulmonx (LUNG) has disclosed Total Debt for 7 consecutive years, with $37.1 million as the latest value for Q3 2025.

  • Quarterly Total Debt changed 0.28% to $37.1 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $37.1 million through Sep 2025, changed 0.28% year-over-year, with the annual reading at $37.2 million for FY2024, 0.18% changed from the prior year.
  • Total Debt for Q3 2025 was $37.1 million at Pulmonx, roughly flat from $37.1 million in the prior quarter.
  • The five-year high for Total Debt was $37.3 million in Q1 2023, with the low at $270000.0 in Q4 2021.
  • Average Total Debt over 5 years is $25.6 million, with a median of $37.1 million recorded in 2025.
  • The sharpest move saw Total Debt plummeted 52.13% in 2021, then skyrocketed 6316.3% in 2022.
  • Over 5 years, Total Debt stood at $270000.0 in 2021, then surged by 6316.3% to $17.3 million in 2022, then surged by 114.98% to $37.2 million in 2023, then dropped by 0.18% to $37.2 million in 2024, then dropped by 0.13% to $37.1 million in 2025.
  • According to Business Quant data, Total Debt over the past three periods came in at $37.1 million, $37.1 million, and $37.2 million for Q3 2025, Q2 2025, and Q1 2025 respectively.